ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,746, issued on June 3, was assigned to GREEN CROSS Corp. (Yongin-si, South Korea) and MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH (Yongin-si, South Korea).
"Bispecific antibody specifically binding to GPNMB and CD3, and use thereof" was invented by Jae Chan Park (Yongin-si, South Korea), Eun Jung Song (Yongin-si, South Korea), So Jung Lim (Yongin-si, South Korea), Jae-Chul Lee (Yongin-si, South Korea), Hae Naem Kwon (Yongin-si, South Korea), Su A Lee (Yongin-si, South Korea), Ok Jae Lim (Yongin-si, South Korea), Mun Kyung Kim (Yongin-si, South Korea), Hyun Jung Cho (Yongin-si, South Korea), Gil-Jung Kim (Yongin-si, South Korea), Jee Won Lee (Yongin-si, South Korea), Sung Keun Kim (Yong...